赛隆药业：注射用替加环素和注射用胸腺法新通过仿制药一致性评价

array(1) { [375865]=> array(2) { [2]=> array(4) { [0]=> string(15) "一致性评价" [1]=> string(9) "仿制药" [2]=> string(12) "胸腺法新" [3]=> string(12) "赛隆药业" } [4]=> array(1) { [0]=> string(19) "同花顺7x24快讯" } } }